INS and type 2 diabetes mellitus: Indeed, systemic inflammation, resistance to insulin’s physiological actions, altered myocardial energetics and MVD are highly implicated in the pathogenesis of HFpEF in patients with obesity, T2D and metabolic syndrome [9, 10].